Clinical trial
Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients
NCT00241462 · AstraZeneca, Industry · Terminated
Key facts
| NCT number | NCT00241462 |
|---|---|
| Title | Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients |
| Official title | Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients |
| Acronym | FORUM |
| Lead sponsor | AstraZeneca, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 150 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Oct 19, 2005 |
| Last update posted | Apr 22, 2009 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: